Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Maria Vittoria Dieci, Silvia Brich et al.|JNCI Journal of the National Cancer Institute|2024Cited by 32
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implicationsGaia Griguolo, V. Guarneri, Maria Vittoria Dieci et al.|ESMO Open|2025Cited by 3
Abstract P4-02-13: Homologous recombination deficiency, RB-loss gene signatures, intrinsic subtype and response to neoadjuvant treatment in HR+/HER2- early breast cancer: a correlative analysis of two phase II trialsGaia Griguolo, Maria Vittoria Dieci, Federica Miglietta et al.|Cancer Research|2023Cited by 2
Association of tumor-infiltrating lymphocytes (TILs) and immune signatures with PAM50 intrinsic subtyping hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of two multicentric neoadjuvant trials.Gaia Griguolo, Valentina Guarneri, Laia Paré et al.|Journal of Clinical Oncology|2024Cited by 1
Abstract PO1-03-09: Transcriptomic profiling of ER-negative and ER-low, HER2-negative breast cancer and its implications on immune regulationGaia Griguolo, Maria Vittoria Dieci, Claudio Vernieri et al.|Cancer Research|2024Cited by 0